Vitamin B12, folate, and Alzheimer's disease

Drug Development Research

Volumn 56, Issue 2, 2002, Pages 111-122

  Wang, H X ^a,b  

^a AGING RESEARCH CENTER   (Sweden)

^b STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

Alzheimer's disease; Cobalamin; Folate; Folic acid; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

AGED; ALZHEIMER DISEASE; AMNESIA; COGNITION; CONFUSION; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; MALE; REVIEW;

EID: 0036597148     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10066     Document Type: Review

References (61)

1. Nutritional anemia: Its understanding and control with special reference to the work of the World Health Organization
2. Cobalamin levels are not reduced in Alzheimer's disease: Results from a population-based study
3. 12 and folate status in acute geropsychiatric in patients: Affective and cognitive characteristics of a vitamin nondeficient population
4. 12 deficiency on older veterans and its relationship to health
5. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study
6. 12, and neuropsychiatric disorders
7. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
8. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects
9. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities
10. 12 deficiency in old age
11. 12, and serum total homocysteine levels in confirmed Alzheimer disease
12. 12 in Alzheimer-type dementia
13. Evidence that some patients with pernicious anemia are not recognized by rediadilution assay for cobalamin in serum
14. Serum vitamin levels and incidence of dementia in a healthy elderly population: A report from the Bronx Longitudinal Aging Study
15. 12 deficiency and dementia
16. The serum vitamin B-12 in the elderly
17. Homocysteine and neurological disease
18. 12 levels in senile dementia and confusional states
19. 12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function
20. Folate status, vascular disease and cognition in elderly Canadians
21. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits
22. Epidemiology of dementia
23. Association between nutritional status and cognitive functioning in a healthy elderly population
24. 12 and folate status on episodic memory functioning: A population-based study of very old adults
25. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
26. Folate and cobalamin in psychiatric illness
27. 12 levels in serum andd cerebrospinal fluid of people with Alzheimer's disease
28. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?
29. Prevalence of folate deficiency. Are age-related behavioral disorders improved by folate administration?
30. Total homocysteine and cognitive decline in a community-based sample of elderly subjects
31. Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states?
32. Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels
33. Nutritional status and cognitive functioning in a normally aging sample: A 6-y reassessment
34. 12 and cognitive impairment in patients with Alzheimer's disease
35. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study
36. Time dependency of cognitive recovery with cobalamin replacement: Report of a pilot study
37. 12 deficiency
38. Total serum homocysteine in senile dementia of Alzheimer type
39. 12 and behavioural and psychological symptoms in Alzheimer's disease
40. 12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia
41. Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements
42. Improvement of cognitive function after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine
43. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
44. Effect of advanced brain atrophy and vitamin deficiency on cognitive functions in nondemented subjects
45. Blood folates deficiencies and cognitive functioning in aging
46. 12 ratio in demented men
47. The role of the polymorphic genes apolipoprotein E and methylene-tetrahydrofolate reductase in the development of dementia of the Alzheimer type
48. Nutritional status of free-living Alzheimer's patients
49. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study
50. Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia
51. Vitamin status and intake as primary determinants of homocysteine in an elderly population
52. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
53. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study
54. RBC folic acid levels and cognitive performance in elderly patients: A preliminary report
55. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians
56. 12: Effects of replacement therapy on dementia
57. Total homocysteine in plasma or serum: Methods and clinical applications
58. The controversy over homocysteine and cardiovascular risk
59. 12 and folate status on episodic memory performance in very old age: A population-based study
60. Low levels of vitamin B12 and folate and Alzheimer's disease incidence
61. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project